Syndicate Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 17-07-2024
- Paid Up Capital ₹ 0.60 M
as on 17-07-2024
- Company Age 12 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.96 Cr
as on 17-07-2024
- Revenue -14.84%
(FY 2023)
- Profit -38.74%
(FY 2023)
- Ebitda -45.29%
(FY 2023)
- Net Worth 42.02%
(FY 2023)
- Total Assets 29.53%
(FY 2023)
About Syndicate Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.60 M.
The company currently has active open charges totaling ₹7.96 Cr.
Saurabh Garg, Arvind Kumar, Jitendra Tiwari, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24232RJ2012PTC038580
- Company No.
038580
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Apr 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Syndicate Diagnostics?
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikas Kothari  | Director | 18-Apr-2012 | Current |
| Saurabh Garg | Director | 18-Apr-2012 | Current |
| Arvind Kumar | Director | 18-Apr-2012 | Current |
| Jitendra Tiwari | Director | 18-Apr-2012 | Current |
| Renu Jain | Director | 18-Apr-2012 | Current |
| Sanjay Jain | Director | 25-Jul-2012 | Current |
Financial Performance of Syndicate Diagnostics.
Syndicate Diagnostics Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.84% decrease. The company also saw a substantial fall in profitability, with a 38.74% decrease in profit. The company's net worth Soared by an impressive increase of 42.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Syndicate Diagnostics?
In 2023, Syndicate Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Poct Science House Private LimitedActive 5 years 11 monthsSaurabh Garg and Jitendra Tiwari are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 19 Aug 2020 | ₹2.19 M | Open |
Others Creation Date: 29 Nov 2019 | ₹9.55 M | Open |
Others Creation Date: 28 Nov 2019 | ₹2.37 Cr | Open |
How Many Employees Work at Syndicate Diagnostics?
Syndicate Diagnostics has a workforce of 25 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Syndicate Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Syndicate Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
